Conflict of interest
H. Kameda has received research grants from AbbVie GK, Astellas Pharma, Chugai Pharmaceutical Co, Ltd., Eisai Co. Ltd., Mitsubishi Tanabe Pharma Co., Nippon Kayaku Co. Ltd., Santen Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd.; speaking fees from AbbVie GK, Astellas Pharma, Bristol–Myers K.K., Chugai Pharmaceutical Co. Ltd., Eisai Co. Ltd., Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Co., Nippon Kayaku Co. Ltd., Pfizer Japan Inc., Santen Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., and UCB Pharma; consultant fees from Eli Lilly Japan K.K., Novartis Pharma K.K. and Sanofi K.K.